Labarai

Afrilu 1, 2022 11:00 DA | Source: Future Market Insights Global and Consulting Pvt.Ltd. Kasuwa ta gaba Insights Global da Consulting Pvt.limited kamfani
DUBAI, Hadaddiyar Daular Larabawa, 1 Afrilu 2022 (GLOBE NEWSWIRE) - Kamar yadda kayan aikin kiwon lafiya ke inganta, haka rayuwar rayuwa take. duka m da marasa lafiya.Cututtuka irin su ciwon daji, sclerosis mai yawa, lalata da kuma lalacewar kwakwalwa sun karu da yawa.
Dukkanin yanayin da ke sama na iya samun sakamako mai lalacewa akan tsarin narkewar mai haƙuri, wanda ke haifar da rashin narkewar abinci, makogwaro da ciwon baki, zawo, da ciwon hanji mai banƙyama.Waɗannan ƙwayoyin cuta suna hana marasa lafiya cin abinci mai ƙarfi.A sakamakon haka, masu samar da kiwon lafiya suna hanzarta karɓar tallafi. na na'urorin ciyar da shiga ciki da kuma ba marasa lafiya isasshen abinci mai gina jiki.
Nemi samfurin don bincike na gaske da cikakkiyar fahimtar kasuwa a https://www.futuremarketinsights.com/reports/sample/rep-gb-12403
Cutar sankarau ta COVID-19 ta tura masana'antar kiwon lafiya cikin wuce gona da iri, a ci gaba da kokarin nemo yuwuwar jiyya ga kwayar cutar mai saurin kisa. Yayin da tattalin arzikin duniya ke fuskantar koma bayan tattalin arziki, kasuwar na'urorin ciyar da abinci za ta kasance karko.
Yayin da marasa lafiya da suka kamu da cutar ke haifar da matsalolin narkewar abinci, buƙatar madadin hanyoyin sarrafa abinci ya karu.Wannan yana ƙara yawan tura na'urorin ciyarwa na ciki.Bugu da ƙari, masu ba da kayayyaki suna mai da hankali kan ƙarfafa cibiyoyin rarraba yanki don tabbatar da samar da kayan aiki ba tare da katsewa ba zuwa wuraren kiwon lafiya daban-daban kungiyoyi.
Yi amfani da ginshiƙi da teburin bayanai da teburin abubuwan ciki don ƙarin koyo game da nazarin rahoton. Jin daɗin tambayar manazarta - https://www.futuremarketinsights.com/ask-question/rep-gb-12403
Bukatar a cikin Amurka, Brazil da Indiya za ta kasance mai ƙarfi musamman, saboda waɗannan ƙasashe sun fi fama da wahala kuma suna ba da sararin samar da kudaden shiga ga masana'antun da aka kafa.
"Na'urorin ciyar da abinci na duniya suna cikin wani lokaci mai girma, wanda ke haifar da kwararar sabbin kayayyaki da fasaha daga masu samar da kayayyaki zuwa kasuwa, wanda ke kawo kasuwa kusa da girma," in ji manazarta FMI. Beijing KellyMed Co., Ltd sanannen kamfani ne a wannan fanni wanda ke ba da mafita ta tsayawa ɗaya na famfon ciyar da shiga ciki da saiti na ciyarwa.
Manyan 'yan wasa a cikin kasuwar na'urorin ciyar da abinci sun hada da ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Kamfanin, da Kamfanin Dynarex, da sauransu. Baya ga wannan, wasu yanki na yanki. 'yan wasan kuma sun mamaye.
A cikin 2014, Cook Medical ya gabatar da bututun ciyarwa na Entuit Thrive Balloon Retention Gastronomy don gastronomy da gastrostomy.Ƙaddamarwar wani ɓangare ne na ƙoƙarin kamfanin don faɗaɗa layin na'urorin ciyarwa.
Boston Scientific yana siyar da nau'ikan na'urori masu shiga ciki, irin su EndoVive Enteral Feeding Tube Kit.Don haɓaka fayil ɗin gastroenterology, kamfanin ya ba da sanarwar ƙaddamar da ƙayyadaddun ƙayyadaddun kasuwa na Exalt Model-D mai amfani da duodenoscope guda ɗaya a cikin Janairu 2020.
A cikin 2016, Cardinal Health ya ƙaddamar da Kangaroo Joey enteral abinci mai gina jiki da famfon ban ruwa don faɗaɗa babban fayil ɗin bututun nasogastric.
Tuntuɓi tallace-tallace don ƙarin taimako a siyan wannan rahoton - https://www.futuremarketinsights.com/checkout/12403
Likitan ICU yana siyar da Lopez Valve da EnFit Lopez Valve Rufe Bututun Shigarwa, waɗanda ke kare ma'aikatan kiwon lafiya daga bayyanar da haɗari ga magudanar ruwa na jiki.
Kasuwar hakar DNA/RNA: Ana sa ran kasuwar hakar DNA/RNA ta duniya zata yi girma a CAGR na 7.7% daga 2022 zuwa 2032.
Kasuwar Gwajin Cystatin C: Ana sa ran kasuwar gwajin cystatin C ta duniya ana tsammanin za a kimanta ta cikin ƙimar ban sha'awa kuma ana tsammanin za ta nuna babban CAGR a lokacin hasashen 2022-2032.
Kasuwancin Reagent na Creatine Kinase: Buƙatar Kasuwar Kasuwa ta Duniya ana tsammanin za ta yi girma a CAGR na 6% daga 2022 zuwa 2032.
Kasuwar Kayayyakin Magungunan Immunochemical: Ana sa ran kasuwar samfuran rigakafi za ta yi girma a CAGR na 7.25% yayin lokacin hasashen, sama da dala biliyan 2.08 a cikin 2021, wanda ya kai darajar dala biliyan 4.5 nan da 2032.
Ma'aikatan Hemostatic don Kasuwar Rufe Rauni: Ana sa ran wakilan hemostatic don kasuwar rufe raunuka za su yi girma a CAGR na 6.3% a lokacin hasashen, sama da dala biliyan 2.4 a shekarar 2021, suna kaiwa darajar dala biliyan 3.5 nan da 2026.
Kasuwar Fasahar Fasaha ta Smart Pill: Ana sa ran kasuwar fasahar kwaya mai wayo za ta yi girma a CAGR na 21% a cikin lokacin hasashen, daga dala miliyan 627.1 a shekarar 2020, kuma za a kimanta dala biliyan 6.176 nan da 2032.
Kasuwar Virology: Ana sa ran kasuwar virology za ta yi girma a CAGR na 5% a lokacin annabta, daga dala biliyan 2.07 a shekarar 2021, ta kai darajar dala biliyan 3.53 nan da 2032.
Kasuwar Magungunan Lupus Erythematosus (SLE): Ana sa ran Kasuwar Magungunan Lupus Erythematosus (SLE) za ta yi girma a CAGR na 5% sama da lokacin hasashen, sama da dala biliyan 183.3 a shekarar 2020, wanda ya kai darajar dala biliyan 329.18 nan da 2032 .
Kasuwar Magungunan Kwayoyin cuta: Ana sa ran kasuwar maganin ƙwayar cuta za ta yi girma a CAGR na 16.7% zuwa $401 miliyan nan da 2026, daga $187 miliyan a 2021.
Kasuwancin Nazarin Numfashi: Ana sa ran kasuwar nazarin numfashi za ta yi girma a CAGR na 17% a cikin lokacin hasashen, daga dala miliyan 613 a shekarar 2021, ya kai darajar dala biliyan 3.4 nan da 2032.
Bayanan Kasuwanci na gaba (FMI) shine babban mai ba da sabis na basirar kasuwa da sabis na ba da shawara, yana bawa abokan ciniki hidima a fiye da kasashe 150. FMI tana da hedikwata a Dubai tare da cibiyoyin bayarwa a Birtaniya, Amurka da India.FMI ta sabon rahoton bincike na kasuwa da kuma taimakon bincike na masana'antu. harkokin kasuwanci suna saduwa da ƙalubale kuma suna yin yanke shawara mai mahimmanci tare da amincewa da tsabta a cikin fuskantar gasa mai tsanani.Al'adarmu da rahotannin bincike na kasuwa suna ba da basirar da za a iya aiwatarwa da ke haifar da ci gaba mai dorewa.Tawagar ƙwararrun ƙwararrun manazarta na ci gaba da bin diddigin abubuwan da ke faruwa da abubuwan da suka faru a cikin masana'antu don tabbatar da tsaro abokan cinikinmu sun shirya don sauye-sauyen bukatun masu amfani.